These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7298586)

  • 21. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone.
    Murphy SM; Owen R; Tyrer P
    Br J Psychiatry; 1989 Apr; 154():529-34. PubMed ID: 2686797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment with diazepam. Investigation of consumption habits and the interaction between psychotherapy and psychopharmacotherapy: a prospective study.
    Balmer R; Battegay R; von Marschall R
    Int Pharmacopsychiatry; 1981; 16(4):221-34. PubMed ID: 7338439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled trial of diazepam withdrawal in chronically anxious outpatients.
    Laughren TP; Battey Y; Greenblatt DJ; Harrop DS
    Acta Psychiatr Scand; 1982 Mar; 65(3):171-9. PubMed ID: 7072511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R; Sartori VA; Seabra ML; Leite JR
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect?
    Rickels K; Case WG; Downing RW; Winokur A
    Adv Biochem Psychopharmacol; 1985; 40():193-204. PubMed ID: 3895840
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and efficacy of long-term diazepam therapy.
    Bowden CL; Fisher JG
    South Med J; 1980 Dec; 73(12):1581-4. PubMed ID: 7444548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.
    Hayward P; Wardle J; Higgitt A; Gray J
    Psychopharmacology (Berl); 1996 Jun; 125(4):392-7. PubMed ID: 8826545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benzodiazepine withdrawal syndrome in low dose dependency].
    Thomas H; Mörchen G
    Psychiatr Prax; 1996 Sep; 23(5):249-50. PubMed ID: 8992523
    [No Abstract]   [Full Text] [Related]  

  • 33. Early response and 8-week treatment outcome in GAD.
    Rynn M; Khalid-Khan S; Garcia-Espana JF; Etemad B; Rickels K
    Depress Anxiety; 2006; 23(8):461-5. PubMed ID: 16845651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
    Lintzeris N; Mitchell TB; Bond A; Nestor L; Strang J
    J Clin Psychopharmacol; 2006 Jun; 26(3):274-83. PubMed ID: 16702892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abecarnil, a new beta-carboline, in the treatment of anxiety disorders.
    Aufdembrinke B
    Br J Psychiatry Suppl; 1998; (34):55-63. PubMed ID: 9829018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety.
    Power KG; Jerrom DW; Simpson RJ; Mitchell M
    Br Med J (Clin Res Ed); 1985 Apr; 290(6477):1246-8. PubMed ID: 3921173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of hydroxyzine in generalized anxiety disorder: controlled double-blind study versus placebo].
    Ferreri M; Hantouche EG; Billardon M
    Encephale; 1994; 20(6):785-91. PubMed ID: 7875114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study.
    Bøe MG; Mygland A; Salvesen R
    Neurology; 2007 Jul; 69(1):26-31. PubMed ID: 17475943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal.
    Gillman MA; Lichtigfeld FJ
    Addict Behav; 2004 Aug; 29(6):1183-7. PubMed ID: 15236821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.